Breast Cancer, 1971-91:
Prevention, Treatment, and Research
PEMD-92-12: Published: Dec 11, 1991. Publicly Released: Dec 11, 1991.
Additional Materials:
- Full Report:
Contact:
Pursuant to a congressional request, GAO reviewed the progress in the prevention and treatment of breast cancer, focusing on what kinds of research were needed to help prevent breast cancer and improve survival rates.
GAO found that: (1) the number of American women diagnosed with breast cancer increases each year, between fiscal year (FY) 1973 and FY 1988 the estimated number of new cases of breast cancer diagnosed grew from 73,000 to 135,000; (2) although more and more women are dying from breast cancer, the adjusted mortality rate has remained relatively constant since FY 1973; (3) the detection, diagnosis, and treatment of breast cancer has improved, since the availability of mammography; (4) based on data from the National Cancer Institute's Surveillance, Epidemiology, and End Results Program, the average size of breast cancer tumors steadily decreased between FY 1977 and FY 1987; (5) the 5-year survival rate for breast cancer patients diagnosed during the period between FY 1981 and FY 1983 was 77 percent, whereas 74.1 percent of the patients diagnosed during the period between FY 1974 and FY 1976 period survived for at least 5 years; (6) although there has been little in the way of facts, evidence, or hard data to support what can be done to improve breast cancer survival rates, a breast cancer patient today has a higher probability of 5-year survival than a patient 20 years ago; (7) it is unlikely that prevention efforts will reduce the incidence of breast cancer, since such identified risk factors as age and heredity can not be changed; and (8) research expenditures for breast cancer are equivalent to or greater than expenditures for other selected conditions.
Jan 14, 2021
-
Medicaid:
Data Completeness and Accuracy Have Improved, Though Not All Standards Have Been MetGAO-21-196: Published: Jan 14, 2021. Publicly Released: Jan 14, 2021.
Jan 4, 2021
-
Medicare Severe Wound Care:
Spending Declines May Reflect Site of Care Changes; Limited Information Is Available on QualityGAO-21-92: Published: Jan 4, 2021. Publicly Released: Jan 4, 2021.
Dec 22, 2020
-
Defense Health Care:
Efforts to Ensure Beneficiaries Access Specialty Care and Receive Timely and Effective CareGAO-21-143: Published: Dec 22, 2020. Publicly Released: Dec 22, 2020.
Dec 16, 2020
-
Medicaid Long-Term Services and Supports:
Access and Quality Problems in Managed Care Demand Improved OversightGAO-21-49: Published: Nov 16, 2020. Publicly Released: Dec 16, 2020.
Dec 14, 2020
-
Drug Pricing Program:
HHS Uses Multiple Mechanisms to Help Ensure Compliance with 340B RequirementsGAO-21-107: Published: Dec 14, 2020. Publicly Released: Dec 14, 2020. -
Substance Use Disorder:
Reliable Data Needed for Substance Abuse Prevention and Treatment Block Grant ProgramGAO-21-58: Published: Dec 14, 2020. Publicly Released: Dec 14, 2020.
Dec 10, 2020
-
Indian Health Service:
Actions Needed to Improve Oversight of Provider Misconduct and Substandard PerformanceGAO-21-97: Published: Dec 10, 2020. Publicly Released: Dec 10, 2020. -
Clinical Labs:
Studies Suggest Biopsy Specimen Misidentification and Contamination Errors Are InfrequentGAO-21-59: Published: Nov 10, 2020. Publicly Released: Dec 10, 2020.
Dec 7, 2020
-
Medicaid:
CMS Needs More Information on States' Financing and Payment Arrangements to Improve OversightGAO-21-98: Published: Dec 7, 2020. Publicly Released: Dec 7, 2020.
Dec 1, 2020
-
Military Health Care:
Defense Health Agency Processes for Responding to Provider Quality and Safety ConcernsGAO-21-160R: Published: Dec 1, 2020. Publicly Released: Dec 1, 2020.
Looking for more? Browse all our products here